These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19651600)

  • 1. Acquired copy number alterations in adult acute myeloid leukemia genomes.
    Walter MJ; Payton JE; Ries RE; Shannon WD; Deshmukh H; Zhao Y; Baty J; Heath S; Westervelt P; Watson MA; Tomasson MH; Nagarajan R; O'Gara BP; Bloomfield CD; Mrózek K; Selzer RR; Richmond TA; Kitzman J; Geoghegan J; Eis PS; Maupin R; Fulton RS; McLellan M; Wilson RK; Mardis ER; Link DC; Graubert TA; DiPersio JF; Ley TJ
    Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12950-5. PubMed ID: 19651600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of acquired copy number alterations and uniparental disomies in cytogenetically normal acute myeloid leukemia using high-resolution single-nucleotide polymorphism analysis.
    Bullinger L; Krönke J; Schön C; Radtke I; Urlbauer K; Botzenhardt U; Gaidzik V; Carió A; Senger C; Schlenk RF; Downing JR; Holzmann K; Döhner K; Döhner H
    Leukemia; 2010 Feb; 24(2):438-49. PubMed ID: 20016533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.
    Barresi V; Romano A; Musso N; Capizzi C; Consoli C; Martelli MP; Palumbo G; Di Raimondo F; Condorelli DF
    Genes Chromosomes Cancer; 2010 Nov; 49(11):1014-23. PubMed ID: 20725993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype.
    Serrano E; Carnicer MJ; Orantes V; Estivill C; Lasa A; Brunet S; Aventín AM; Sierra J; Nomdedéu JF
    Leuk Lymphoma; 2008 Jun; 49(6):1178-83. PubMed ID: 18452069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.
    Koh KN; Lee JO; Seo EJ; Lee SW; Suh JK; Im HJ; Seo JJ
    J Korean Med Sci; 2014 Jul; 29(7):926-33. PubMed ID: 25045224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copy-number analysis identified new prognostic marker in acute myeloid leukemia.
    Nibourel O; Guihard S; Roumier C; Pottier N; Terre C; Paquet A; Peyrouze P; Geffroy S; Quentin S; Alberdi A; Abdelali RB; Renneville A; Demay C; Celli-Lebras K; Barbry P; Quesnel B; Castaigne S; Dombret H; Soulier J; Preudhomme C; Cheok MH
    Leukemia; 2017 Mar; 31(3):555-564. PubMed ID: 27686867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Close correlation of copy number aberrations detected by next-generation sequencing with results from routine cytogenetics in acute myeloid leukemia.
    Vosberg S; Herold T; Hartmann L; Neumann M; Opatz S; Metzeler KH; Schneider S; Graf A; Krebs S; Blum H; Baldus CD; Hiddemann W; Spiekermann K; Bohlander SK; Mansmann U; Greif PA
    Genes Chromosomes Cancer; 2016 Jul; 55(7):553-67. PubMed ID: 27015608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommon.
    Ramsingh G; Jacoby MA; Shao J; De Jesus Pizzaro RE; Shen D; Trissal M; Getz AH; Ley TJ; Walter MJ; Link DC
    Blood; 2013 Oct; 122(15):e44-51. PubMed ID: 24009227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern.
    Hollink IH; van den Heuvel-Eibrink MM; Arentsen-Peters ST; Pratcorona M; Abbas S; Kuipers JE; van Galen JF; Beverloo HB; Sonneveld E; Kaspers GJ; Trka J; Baruchel A; Zimmermann M; Creutzig U; Reinhardt D; Pieters R; Valk PJ; Zwaan CM
    Blood; 2011 Sep; 118(13):3645-56. PubMed ID: 21813447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia.
    Radtke I; Mullighan CG; Ishii M; Su X; Cheng J; Ma J; Ganti R; Cai Z; Goorha S; Pounds SB; Cao X; Obert C; Armstrong J; Zhang J; Song G; Ribeiro RC; Rubnitz JE; Raimondi SC; Shurtleff SA; Downing JR
    Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12944-9. PubMed ID: 19651601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia.
    Krönke J; Bullinger L; Teleanu V; Tschürtz F; Gaidzik VI; Kühn MW; Rücker FG; Holzmann K; Paschka P; Kapp-Schwörer S; Späth D; Kindler T; Schittenhelm M; Krauter J; Ganser A; Göhring G; Schlegelberger B; Schlenk RF; Döhner H; Döhner K
    Blood; 2013 Jul; 122(1):100-8. PubMed ID: 23704090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.
    Tiu RV; Gondek LP; O'Keefe CL; Huh J; Sekeres MA; Elson P; McDevitt MA; Wang XF; Levis MJ; Karp JE; Advani AS; Maciejewski JP
    J Clin Oncol; 2009 Nov; 27(31):5219-26. PubMed ID: 19770377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel genomic aberrations in AML-M5 in a level of array CGH.
    Zhang R; Lee JY; Wang X; Xu W; Hu X; Lu X; Niu Y; Tang R; Li S; Li Y
    PLoS One; 2014; 9(4):e87637. PubMed ID: 24727659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal minimal critical regions in therapy-related leukemia appear different from those of de novo leukemia by high-resolution aCGH.
    Itzhar N; Dessen P; Toujani S; Auger N; Preudhomme C; Richon C; Lazar V; Saada V; Bennaceur A; Bourhis JH; de Botton S; Bernheim A
    PLoS One; 2011 Feb; 6(2):e16623. PubMed ID: 21339820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia.
    Walker CJ; Kohlschmidt J; Eisfeld AK; Mrózek K; Liyanarachchi S; Song C; Nicolet D; Blachly JS; Bill M; Papaioannou D; Oakes CC; Giacopelli B; Genutis LK; Maharry SE; Orwick S; Archer KJ; Powell BL; Kolitz JE; Uy GL; Wang ES; Carroll AJ; Stone RM; Byrd JC; de la Chapelle A; Bloomfield CD
    Clin Cancer Res; 2019 Nov; 25(21):6524-6531. PubMed ID: 31375516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of SNP Array Abnormalities in Patients with DE NOVO Acute Myeloid Leukemia with Normal Karyotype.
    Ibáñez M; Such E; Onecha E; Gómez-Seguí I; Liquori A; Sellés J; Hervás-Marín D; Barragán E; Ayala R; LLop M; López-Pavía M; Rapado I; Neef A; Sanjuan-Pla A; Sargas C; Gonzalez-Romero E; Boluda-Navarro M; Andreu R; Senent L; Montesinos P; Martínez-López J; Angel Sanz M; Sanz G; Cervera J
    Sci Rep; 2020 Apr; 10(1):5904. PubMed ID: 32246042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micro-RNAs and copy number changes: new levels of gene regulation in acute myeloid leukemia.
    Larson RA
    Chem Biol Interact; 2010 Mar; 184(1-2):21-5. PubMed ID: 19822134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genetic landscape of paediatric de novo acute myeloid leukaemia as defined by single nucleotide polymorphism array and exon sequencing of 100 candidate genes.
    Olsson L; Zettermark S; Biloglav A; Castor A; Behrendtz M; Forestier E; Paulsson K; Johansson B
    Br J Haematol; 2016 Jul; 174(2):292-301. PubMed ID: 27022003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse.
    Wang ES; Sait SN; Gold D; Mashtare T; Starostik P; Ford LA; Wetzler M; Nowak NJ; Deeb G
    Cancer Genet Cytogenet; 2010 Oct; 202(2):101-7. PubMed ID: 20875872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-nucleotide polymorphism-array improves detection rate of genomic alterations in core-binding factor leukemia.
    Costa AR; Vasudevan A; Krepischi A; Rosenberg C; Chauffaille Mde L
    Med Oncol; 2013; 30(2):579. PubMed ID: 23636907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.